Papers: 5 Feb 2016 - 12 Feb 2016 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Prevalence of Multiple Sclerosis in the Republic of Moldova. Marcoci C, Lisnic V, Gavriliuc M, Odainic O, Sangheli M, Belenciuc A, Leone M A, Casetta I, Pugliatti M Neuroepidemiology. 2016 Feb 6; 46(3):166-172. Epub 2016 Feb 06. PMID: 26849377. Abstract Editors' Pick Reassessing the risk of natalizumab-associated PML. Berger JR, Fox RJ J Neurovirol. 2016 Feb 3. Epub 2016 Feb 03. PMID: 26843383. Abstract Editors' Pick Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung H-P, Montalban X, Uitdehaag B M, et al. Lancet. 2016 Jan 27. Epub 1969 Dec 31. PMID: 26827074. Abstract Predicted structure of MIF/CD74 and RTL1000/CD74 complexes. Meza-Romero R, Benedek G, Leng L, Bucala R, Vandenbark AA Metab Brain Dis. 2016 Feb 6. PMID: 26851955. Abstract Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients. Hojjat S-P, Cantrell C G, Carroll TJ, Vitorino R, Feinstein A, Zhang L, Symons SP, Morrow SA, Lee L, O'Connor P, et al. Mult Scler. 2016 Feb 4. PMID: 26846987. Abstract Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol. Vormfelde S V, Ortler S, Ziemssen T JMIR Res Protoc. 2016; 5(1):e23. PMID: 26846334. Abstract Incidence of Radiologically Isolated Syndrome: A Population-Based Study. Forslin Y, Granberg T, Jumah AA, Shams S, Aspelin P, Kristoffersen-Wiberg M, Martola J, Fredrikson S AJNR Am J Neuroradiol. 2016 Feb 4. PMID: 26846927. Abstract Dark microglia: A new phenotype predominantly associated with pathological states. Bisht K, Sharma KP, Lecours C, Sánchez M G, El Hajj H, Milior G, Olmos-Alonso A, Gómez-Nicola D, Luheshi G, Vallières L, et al. Glia. 2016 Feb 5. PMID: 26847266. Abstract Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review. Barreto L C L S, Oliveira F S, Nunes P S, de França Costa I M P, Garcez C A, Goes G M, Neves E L A, de Souza Siqueira Quintans J, de Souza Araújo A A Neuroepidemiology. 2016 Feb 6; 46(3):157-165. Epub 2016 Feb 06. PMID: 26849231. Abstract Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue. Pravatà E, Zecca C, Sestieri C, Caulo M, Riccitelli G C, Rocca M A, Filippi M, Cianfoni A, Gobbi C Mult Scler. 2016 Feb 4. PMID: 26846988. Abstract Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation. Lv Z J, Liu Y, Miao H, Leng Z Q, Guo J H, Liu J J Biomed Mater Res B Appl Biomater. 2016 Feb 5. PMID: 26849161. Abstract Fatigue in multiple sclerosis: The contribution of occult white matter damage. Bisecco A, Caiazzo G, D'Ambrosio A, Sacco R, Bonavita S, Docimo R, Cirillo M, Pagani E, Filippi M, Esposito F, et al. Mult Scler. 2016 Feb 4. PMID: 26846989. Abstract Comparison of LC-UV and LC-MS methods for simultaneous determination of teriflunomide, dimethyl fumarate and fampridine in human plasma, application to rat PK study. Suneetha A, Rajeswari RK Biomed Chromatogr. 2016 Feb 5. PMID: 26849839. Abstract Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study. Sørensen PS, Sellebjerg F, Lycke J, Färkkilä M, Créange A, Lund CG, Schluep M, Frederiksen JL, Stenager E, Pfleger C, et al. Eur J Neurol. 2016 Feb 5. PMID: 26848561. Abstract Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders. Frederick MC, Cameron MH Curr Neurol Neurosci Rep. 2016 Mar; 16(3):26. PMID: 26847090. Abstract Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking. Goldman SA Cell Stem Cell. 2016 Feb 4; 18(2):174-88. PMID: 26849304. Abstract The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups. JadidMilani M, Ashktorab T, AbedSaeedi Z, AlaviMajd H Int J Nurs Pract. 2015 Dec; 21(6):725-32. PMID: 26847031. Abstract Demyelinating disease: NMO spectrum disorders: clinical or molecular classification? Pittock SJ Nat Rev Neurol. 2016 Mar; 12(3):129-30. Epub 2016 Feb 05. PMID: 26846455. Abstract Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation. Kuypers NJ, Bankston AN, Howard RM, Beare JE, Whittemore SR J Neurosci. 2016 Feb 3; 36(5):1698-710. PMID: 26843650. Abstract Cutaneous adverse events in multiple sclerosis patients treated with daclizumab. Cortese I, Ohayon J, Fenton K, Lee C-C, Raffeld M, Cowen EW, DiGiovanna JJ, Bielekova B Neurology. 2016 Feb 3. PMID: 26843560. Abstract Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong A H Y, et al. Neurology. 2016 Feb 3. PMID: 26843559. Abstract The Link between CD6 and Autoimmunity: Genetic and Cellular Associations. Kofler DM, Farkas A, von Bergwelt-Baildon M, Hafler DA Curr Drug Targets. 2016 Jan 31. PMID: 26844569. Abstract A confusing case of multiple sclerosis and central nervous system graft versus host disease. Yoon B-N, Ha C K, Lee K-W, Park S-H, Sung J-J Korean J Intern Med. 2016 Feb 3. PMID: 26842106. Abstract Microglia: A Unique Versatile Cell in the Central Nervous System. Masuda T, Prinz M ACS Chem Neurosci. 2016 Feb 4. PMID: 26844374. Abstract Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications. Liu C, Wei H, Gong N-J, Cronin M, Dibb R, Decker K Tomography. 2015 Sep; 1(1):3-17. PMID: 26844301. Abstract Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors. Marck C H, Neate S L, Taylor K L, Weiland T J, Jelinek G A PLoS One. 2016; 11(2):e0148573. Epub 2016 Feb 05. PMID: 26849357. Abstract Nongenomic actions of neurosteroid pregnenolone and its metabolites. Weng J-H, Chung B-C Steroids. 2016 Feb 1. PMID: 26844377. Abstract Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, et al. PLoS One. 2016; 11(2):e0147567. Epub 2016 Feb 05. PMID: 26849221. Abstract Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE). Futatsuya K, Kakeda S, Yoneda T, Ueda I, Watanabe K, Moriya J, Murakami Y, Ide S, Ogasawara A, Ohnari N, et al. Magn Reson Med Sci. 2016 Feb 3. PMID: 26841855. Abstract Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients. Zhang F, Gao C, Ma X, Peng X, Zhang R, Kong D, Simard AR, Hao J CNS Neurosci Ther. 2016 Feb 4. PMID: 26842313. Abstract [The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis]. Murav'eva SV, Bisaga GN, Pronin SV, Bryakileva TV, Shelepin YE Zh Vyssh Nerv Deiat Im I P Pavlova. 2015 Nov-Dec; 65(6):711-9. PMID: 26841659. Abstract The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination. Tomas-Roig J, Wirths O, Salinas-Riester G, Havemann-Reinecke U CNS Neurosci Ther. 2016 Feb 4. PMID: 26842941. Abstract Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis. Stanisavljević S, Lukić J, Momčilović M, Miljković M, Jevtić B, Kojić M, Golić N, Mostarica Stojković M, Miljković D Benef Microbes. 2016 Feb 3:1-12. PMID: 26839070. Abstract A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways. Kim B-W, More S V, Yun Y-S, Ko H-M, Kwak J-H, Lee H, Suk K, Kim I-S, Choi D-K Acta Pharmacol Sin. 2016 Feb 1. PMID: 26838070. Abstract Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review. Zhu T H, Nakamura M, Abrouk M, Farahnik B, Koo J, Bhutani T J Dermatolog Treat. 2016 Feb 2:1-8. PMID: 26837667. Abstract Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability. Allali G, Laidet M, Herrmann FR, Armand S, Elsworth-Edelsten C, Assal F, Lalive PH J Neural Transm (Vienna). 2016 Feb 4. Epub 2016 Feb 04. PMID: 26846418. Abstract A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation. Bonnier G, Kober T, Schluep M, Du Pasquier R, Krueger G, Meuli R, Granziera C, Roche A PLoS One. 2016; 11(2):e0148631. Epub 2016 Feb 04. PMID: 26845760. Abstract Therapeutic options in neuromyelitis optica spectrum disorders. Kitley J, Palace J Expert Rev Neurother. 2016 Feb 3. PMID: 26840802. Abstract Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load. Pareto D, Sastre-Garriga J, Aymerich FX, Auger C, Tintoré M, Montalban X, Rovira A Neuroradiology. 2016 Feb 4. Epub 2016 Feb 04. PMID: 26847633. Abstract Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy. Adachi H, Ishihara K, Tachibana H, Oka N, Higuchi Y, Takashima H, Yoneda Y, Kageyama Y Muscle Nerve. 2016 Feb 3. PMID: 26840509. Abstract Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Opsahl JA, Vaudel M, Guldbrandsen A, Aasebø E, van Pesch V, Franciotta D, Myhr K-M, Barsnes H, Berle M, Torkildsen Ø, et al. Proteomics. 2016 Feb 3. PMID: 26841090. Abstract Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study. Faivre A, Robinet E, Guye M, Rousseau C, Maarouf A, Le Troter A, Zaaraoui W, Rico A, Crespy L, Soulier E, et al. Mult Scler. 2016 Feb 2. PMID: 26838014. Abstract Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study. Preziosa P, Rocca MA, Pagani E, Stromillo M L, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, et al. Hum Brain Mapp. 2016 Feb 2. PMID: 26833969. Abstract A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis. Plavina T, Fox EJ, Lucas N, Muralidharan K K, Mikol D J Clin Pharmacol. 2016 Feb 2. PMID: 26835603. Abstract Clinicopathological features in anterior visual pathway in neuromyelitis optica. Hokari M, Yokoseki A, Arakawa M, Saji E, Yanagawa K, Yanagimura F, Toyoshima Y, Okamoto K, Ueki S, Hatase T, et al. Ann Neurol. 2016 Feb 2. PMID: 26836302. Abstract International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Tan C T, Mao Z, Qiu W, Hu X, Wingerchuk DM, Weinshenker BG Neurology. 2016 Feb 2; 86(5):491-2. PMID: 26833940. Abstract Reliability and Validity of Ratings of Perceived Exertion in Persons with Multiple Sclerosis. Cleland BT, Ingraham BA, Pitluck MC, Woo D, Ng AV Arch Phys Med Rehabil. 2016 Jan 30. PMID: 26836954. Abstract SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent. Muñoz-Culla M, Irizar H, Sáenz-Cuesta M, Castillo-Triviño T, Osorio-Querejeta I, Sepúlveda L, de Munain A L, Olascoaga J, Otaegui D Sci Rep. 2016; 6:20126. PMID: 26831009. Abstract Modeling the course and outcomes of MS is statistical twaddle-No. Bergamaschi R, Montomoli C Mult Scler. 2016 Feb; 22(2):142-4. PMID: 26830394. Abstract Clustering of autoimmune diseases in patients with rosacea. Egeberg A, Hansen P R, Gislason G H, Thyssen J P J Am Acad Dermatol. 2016 Jan 30. PMID: 26830864. Abstract Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes. Taylor BV Mult Scler. 2016 Feb; 22(2):140-2. PMID: 26830393. Abstract Multiple sclerosis - New treatment modalities. Totaro R, Di Carmine C, Marini C, Carolei A Indian J Med Res. 2015 Dec; 142(6):647-54. PMID: 26831413. Abstract Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy. Shan N-N, Dong L-L, Zhang X-M, Liu X, Li Y Crit Rev Oncol Hematol. 2016 Jan 19. PMID: 26830007. Abstract Transient global amnesia revealing multiple sclerosis. Ozkul-Wermester O, Lefaucheur R, Macaigne V, Guegan-Massardier E, Bourre B Presse Med. 2016 Jan 29. PMID: 26830923. Abstract Correction: The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model. Lee Y E, An J, Lee K-H, Kim S S, Song H J, Pyeon H, Nam H, Kang K, Joo K M PLoS One. 2016; 11(2):e0148720. Epub 2016 Feb 03. PMID: 26840900. Abstract High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients. Hecker M, Fitzner B, Wendt M, Lorenz P, Flechtner K, Steinbeck F, Schröder I, Thiesen H-J, Zettl U K Mol Cell Proteomics. 2016 Feb 1. PMID: 26831522. Abstract Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score. Schiavolin S, Giovannetti A M, Leonardi M, Brenna G, Brambilla L, Confalonieri P, Frangiamore R, Mantegazza R, Moscatelli M, Clerici V T, et al. Neurol Sci. 2016 Feb 3. Epub 2016 Feb 03. PMID: 26842465. Abstract Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. Leszek J, Barreto GE, Gąsiorowski K, Koutsouraki E, Ávila-Rodrigues M, Aliev G CNS Neurol Disord Drug Targets. 2016 Feb 2. PMID: 26831258. Abstract Psoriasis and comorbidities. Epidemiological studies. Egeberg A Dan Med J. 2016 Feb; 63(2). PMID: 26836804. Abstract Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome. Canaday S, Rompala J, Rowles J, Fisher J, Holt D J Extra Corpor Technol. 2015 Dec; 47(4):228-30. PMID: 26834285. Abstract Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells. Li Y, Du X-L, He B-P Neurochem Res. 2016 Feb 3. Epub 2016 Feb 03. PMID: 26842931. Abstract Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder. Kim W, Lee J E, Kim S, Huh S Y, Hyun J W, Jeong I H, Park M S, Cho J Y, Lee S H, Lee K S, et al. J Clin Neurol. 2016 Jan 28. PMID: 26833983. Abstract Primary progressive multiple sclerosis-why we are failing. Segal BM, Stüve O Lancet. 2016 Jan 27. Epub 1969 Dec 31. PMID: 26827076. Abstract [Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy]. Nogués MA, Varela FJ, Seminario G, Insúa MC, Bezrodnik L Medicina (B Aires). 2016; 76(1):36-9. PMID: 26826992. Abstract HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis. Swaroop S, Sengupta N, Suryawanshi A R, Adlakha YK, Basu A J Neuroinflammation. 2016; 13(1):27. Epub 2016 Feb 02. PMID: 26838598. Abstract Sjögren's syndrome and multiple sclerosis: Two sides of the same coin? Masi G, Annunziata P Autoimmun Rev. 2016 Jan 28. PMID: 26827908. Abstract Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors. Tang X, Wang S, Bai Y, Wu J, Fu L, Li M, Xu Q, Xu Z-Q D, Alex Zhang Y, Chen Z Stem Cell Res. 2016 Jan 15; 16(2):236-242. PMID: 26826927. Abstract [Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis]. Di Marco J, De Broglie C, Manceau P, Weglinski L, Lebreton F, Verrollet D, Amarenco G Prog Urol. 2016 Jan 27. PMID: 26826771. Abstract Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis. Ensari I, Sandroff BM, Motl RW Anxiety Stress Coping. 2016 Feb 1:1-29. PMID: 26828264. Abstract Depression during multiple sclerosis relapse: relation to disability and relapse severity. Šabanagić-Hajrić S, Suljić E, Sulejmanpašić-Arslanagić G Med Glas (Zenica). 2016 Feb 1; 13(1):44-9. PMID: 26827706. Abstract White Matter MS-Lesion Segmentation Using a Geometric Brain Model. Strumia M, Schmidt F, Anastasopoulos C, Granziera C, Krueger G, Brox T IEEE Trans Med Imaging. 2016 Jan 26. PMID: 26829786. Abstract Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients. Teniente-Serra A, Grau-López L, Mansilla JM, Fernández-Sanmartín M, Ester Condins A, Ramo-Tello C, Martínez-Cáceres E Autoimmunity. 2016 Feb 1:1-10. PMID: 26829210. Abstract Cardiac Sympathetic Hyperactivity in a Patient with Guillain-Barré Syndrome: An Analysis Using Cardiac [(123)I] Metaiodobenzylguanidine (MIBG) Scintigraphy. Tanaka Y, Satomi K Intern Med. 2016; 55(3):299-302. Epub 2016 Feb 01. PMID: 26831028. Abstract A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility. O'Meara RW, Cummings SE, Michalski J-P, Kothary R BMC Neurosci. 2016; 17(1):7. Epub 2016 Feb 01. PMID: 26831726. Abstract A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy. Hong Y B, Joo J, Hyun Y S, Kwak G, Choi Y-R, Yeo H K, Jwa D H, Kim E J, Mo W M, Nam S H, et al. PLoS Genet. 2016 Feb; 12(2):e1005829. Epub 2016 Feb 01. PMID: 26828946. Abstract OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages. D'Souza CA, Zhao F L, Li X, Xu Y, Dunn SE, Zhang L PLoS One. 2016; 11(2):e0148439. Epub 2016 Feb 01. PMID: 26828924. Abstract IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. Lin C-C, Bradstreet TR, Schwarzkopf EA, Jarjour NN, Chou C, Archambault AS, Sim J, Zinselmeyer BH, Carrero JA, Wu GF, et al. J Exp Med. 2016 Feb 8; 213(2):251-71. Epub 2016 Feb 01. PMID: 26834156. Abstract RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis. Lee J-K, Kannarkat GT, Chung J, Joon Lee H, Graham KL, Tansey MG J Neuroinflammation. 2016; 13(1):24. Epub 2016 Feb 01. PMID: 26831924. Abstract Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Wang D, Li S-P, Fu J-S, Bai L, Guo L Int J Dev Neurosci. 2016 Apr; 49:60-6. Epub 2016 Jan 28. PMID: 26827767. Abstract Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination. Lin Y C, Winokur P, Blake A, Wu T, Manischewitz J, King LR, Romm E, Golding H, Bielekova B Neurol Neuroimmunol Neuroinflamm. 2016 Feb; 3(1):e196. Epub 2016 Jan 27. PMID: 26848487. Abstract Neurorehabilitation for Multiple Sclerosis Patients with Emotional Dysfunctions. Hung Y, Yarmak P Front Neurol. 2015; 6:272. Epub 2016 Jan 25. PMID: 26834694. Abstract Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis. Zhou FQ, Gong HH, Chen Q, Wang B, Peng Y, Zhuang Y, Zee C-S Front Hum Neurosci. 2016; 10:2. Epub 2016 Jan 25. PMID: 26834600. Abstract Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt. El-Tallawy HN, Farghaly W M, Badry R, Metwally NA, Shehata GA, Rageh TA, Hamed M A E, Kandil MR Neuropsychiatr Dis Treat. 2016; 12:155-8. Epub 2016 Jan 13. PMID: 26834477. Abstract Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis. Moon Y, Wajda DA, Motl RW, Sosnoff JJ Mult Scler Int. 2015; 2015:964790. Epub 2015 Dec 30. PMID: 26843986. Abstract The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Storoni M, Plant GT Mult Scler Int. 2015; 2015:681289. Epub 2015 Dec 29. PMID: 26839705. Abstract Medicinal cannabis. Murnion B Aust Prescr. 2015 Dec; 38(6):212-5. Epub 2015 Dec 01. PMID: 26843715. Abstract Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis. Kolahkaj B, Zargar F Nurs Midwifery Stud. 2015 Dec; 4(4):e29655. Epub 2015 Dec 01. PMID: 26835467. Abstract Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder. Roman-Filip C, Ungureanu A, Cernuşcă-Miţaru M Neurol Neurochir Pol. 2016; 50(1):55-8. Epub 2015 Nov 24. PMID: 26851692. Abstract Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis. Sharma P, Morrow SA, Owen RJ Prim Care Companion CNS Disord. 2015; 17(5). Epub 2015 Oct 29. PMID: 26835163. Abstract Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder. Hyun J-W, Kim S-H, Jeong I H, Joung A, Kim J-H, Cho H J, Kim J H, Kim H J Sleep Med. 2016 Jan; 17:121-3. Epub 2015 Oct 22. PMID: 26847984. Abstract Bevacizumab is safe in acute relapses of neuromyelitis optica. Mealy MA, Shin K, John G, Levy M Clin Exp Neuroimmunol. 2015 Nov 1; 6(4):413-418. Epub 2015 Aug 24. PMID: 26834844. Abstract Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosis. Ezeugwu V, Klaren RE, Hubbard EA, Manns P T, Motl RW Prev Med Rep. 2015; 2:241-6. Epub 2015 Apr 01. PMID: 26844077. Abstract Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy. Motuzova Y, di Sapio A, Capobianco M, Sala A, Marnetto F, Malucchi S, Bertolotto A Neurol Ther. 2015 Jun; 4(1):53-60. Epub 2015 Mar 06. PMID: 26847675. Abstract A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms. Souri E, Zargarpoor M, Mottaghi S, Ahmadkhaniha R, Kebriaeezadeh A Sci Pharm. 2015; 83(1):85-93. Epub 2014 Sep 23. PMID: 26839803. Abstract
Editors' Pick Prevalence of Multiple Sclerosis in the Republic of Moldova. Marcoci C, Lisnic V, Gavriliuc M, Odainic O, Sangheli M, Belenciuc A, Leone M A, Casetta I, Pugliatti M Neuroepidemiology. 2016 Feb 6; 46(3):166-172. Epub 2016 Feb 06. PMID: 26849377. Abstract
Editors' Pick Reassessing the risk of natalizumab-associated PML. Berger JR, Fox RJ J Neurovirol. 2016 Feb 3. Epub 2016 Feb 03. PMID: 26843383. Abstract
Editors' Pick Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung H-P, Montalban X, Uitdehaag B M, et al. Lancet. 2016 Jan 27. Epub 1969 Dec 31. PMID: 26827074. Abstract
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes. Meza-Romero R, Benedek G, Leng L, Bucala R, Vandenbark AA Metab Brain Dis. 2016 Feb 6. PMID: 26851955. Abstract
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients. Hojjat S-P, Cantrell C G, Carroll TJ, Vitorino R, Feinstein A, Zhang L, Symons SP, Morrow SA, Lee L, O'Connor P, et al. Mult Scler. 2016 Feb 4. PMID: 26846987. Abstract
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol. Vormfelde S V, Ortler S, Ziemssen T JMIR Res Protoc. 2016; 5(1):e23. PMID: 26846334. Abstract
Incidence of Radiologically Isolated Syndrome: A Population-Based Study. Forslin Y, Granberg T, Jumah AA, Shams S, Aspelin P, Kristoffersen-Wiberg M, Martola J, Fredrikson S AJNR Am J Neuroradiol. 2016 Feb 4. PMID: 26846927. Abstract
Dark microglia: A new phenotype predominantly associated with pathological states. Bisht K, Sharma KP, Lecours C, Sánchez M G, El Hajj H, Milior G, Olmos-Alonso A, Gómez-Nicola D, Luheshi G, Vallières L, et al. Glia. 2016 Feb 5. PMID: 26847266. Abstract
Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review. Barreto L C L S, Oliveira F S, Nunes P S, de França Costa I M P, Garcez C A, Goes G M, Neves E L A, de Souza Siqueira Quintans J, de Souza Araújo A A Neuroepidemiology. 2016 Feb 6; 46(3):157-165. Epub 2016 Feb 06. PMID: 26849231. Abstract
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue. Pravatà E, Zecca C, Sestieri C, Caulo M, Riccitelli G C, Rocca M A, Filippi M, Cianfoni A, Gobbi C Mult Scler. 2016 Feb 4. PMID: 26846988. Abstract
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation. Lv Z J, Liu Y, Miao H, Leng Z Q, Guo J H, Liu J J Biomed Mater Res B Appl Biomater. 2016 Feb 5. PMID: 26849161. Abstract
Fatigue in multiple sclerosis: The contribution of occult white matter damage. Bisecco A, Caiazzo G, D'Ambrosio A, Sacco R, Bonavita S, Docimo R, Cirillo M, Pagani E, Filippi M, Esposito F, et al. Mult Scler. 2016 Feb 4. PMID: 26846989. Abstract
Comparison of LC-UV and LC-MS methods for simultaneous determination of teriflunomide, dimethyl fumarate and fampridine in human plasma, application to rat PK study. Suneetha A, Rajeswari RK Biomed Chromatogr. 2016 Feb 5. PMID: 26849839. Abstract
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study. Sørensen PS, Sellebjerg F, Lycke J, Färkkilä M, Créange A, Lund CG, Schluep M, Frederiksen JL, Stenager E, Pfleger C, et al. Eur J Neurol. 2016 Feb 5. PMID: 26848561. Abstract
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders. Frederick MC, Cameron MH Curr Neurol Neurosci Rep. 2016 Mar; 16(3):26. PMID: 26847090. Abstract
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking. Goldman SA Cell Stem Cell. 2016 Feb 4; 18(2):174-88. PMID: 26849304. Abstract
The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups. JadidMilani M, Ashktorab T, AbedSaeedi Z, AlaviMajd H Int J Nurs Pract. 2015 Dec; 21(6):725-32. PMID: 26847031. Abstract
Demyelinating disease: NMO spectrum disorders: clinical or molecular classification? Pittock SJ Nat Rev Neurol. 2016 Mar; 12(3):129-30. Epub 2016 Feb 05. PMID: 26846455. Abstract
Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation. Kuypers NJ, Bankston AN, Howard RM, Beare JE, Whittemore SR J Neurosci. 2016 Feb 3; 36(5):1698-710. PMID: 26843650. Abstract
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab. Cortese I, Ohayon J, Fenton K, Lee C-C, Raffeld M, Cowen EW, DiGiovanna JJ, Bielekova B Neurology. 2016 Feb 3. PMID: 26843560. Abstract
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong A H Y, et al. Neurology. 2016 Feb 3. PMID: 26843559. Abstract
The Link between CD6 and Autoimmunity: Genetic and Cellular Associations. Kofler DM, Farkas A, von Bergwelt-Baildon M, Hafler DA Curr Drug Targets. 2016 Jan 31. PMID: 26844569. Abstract
A confusing case of multiple sclerosis and central nervous system graft versus host disease. Yoon B-N, Ha C K, Lee K-W, Park S-H, Sung J-J Korean J Intern Med. 2016 Feb 3. PMID: 26842106. Abstract
Microglia: A Unique Versatile Cell in the Central Nervous System. Masuda T, Prinz M ACS Chem Neurosci. 2016 Feb 4. PMID: 26844374. Abstract
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications. Liu C, Wei H, Gong N-J, Cronin M, Dibb R, Decker K Tomography. 2015 Sep; 1(1):3-17. PMID: 26844301. Abstract
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors. Marck C H, Neate S L, Taylor K L, Weiland T J, Jelinek G A PLoS One. 2016; 11(2):e0148573. Epub 2016 Feb 05. PMID: 26849357. Abstract
Nongenomic actions of neurosteroid pregnenolone and its metabolites. Weng J-H, Chung B-C Steroids. 2016 Feb 1. PMID: 26844377. Abstract
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, et al. PLoS One. 2016; 11(2):e0147567. Epub 2016 Feb 05. PMID: 26849221. Abstract
Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE). Futatsuya K, Kakeda S, Yoneda T, Ueda I, Watanabe K, Moriya J, Murakami Y, Ide S, Ogasawara A, Ohnari N, et al. Magn Reson Med Sci. 2016 Feb 3. PMID: 26841855. Abstract
Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients. Zhang F, Gao C, Ma X, Peng X, Zhang R, Kong D, Simard AR, Hao J CNS Neurosci Ther. 2016 Feb 4. PMID: 26842313. Abstract
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis]. Murav'eva SV, Bisaga GN, Pronin SV, Bryakileva TV, Shelepin YE Zh Vyssh Nerv Deiat Im I P Pavlova. 2015 Nov-Dec; 65(6):711-9. PMID: 26841659. Abstract
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination. Tomas-Roig J, Wirths O, Salinas-Riester G, Havemann-Reinecke U CNS Neurosci Ther. 2016 Feb 4. PMID: 26842941. Abstract
Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis. Stanisavljević S, Lukić J, Momčilović M, Miljković M, Jevtić B, Kojić M, Golić N, Mostarica Stojković M, Miljković D Benef Microbes. 2016 Feb 3:1-12. PMID: 26839070. Abstract
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways. Kim B-W, More S V, Yun Y-S, Ko H-M, Kwak J-H, Lee H, Suk K, Kim I-S, Choi D-K Acta Pharmacol Sin. 2016 Feb 1. PMID: 26838070. Abstract
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review. Zhu T H, Nakamura M, Abrouk M, Farahnik B, Koo J, Bhutani T J Dermatolog Treat. 2016 Feb 2:1-8. PMID: 26837667. Abstract
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability. Allali G, Laidet M, Herrmann FR, Armand S, Elsworth-Edelsten C, Assal F, Lalive PH J Neural Transm (Vienna). 2016 Feb 4. Epub 2016 Feb 04. PMID: 26846418. Abstract
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation. Bonnier G, Kober T, Schluep M, Du Pasquier R, Krueger G, Meuli R, Granziera C, Roche A PLoS One. 2016; 11(2):e0148631. Epub 2016 Feb 04. PMID: 26845760. Abstract
Therapeutic options in neuromyelitis optica spectrum disorders. Kitley J, Palace J Expert Rev Neurother. 2016 Feb 3. PMID: 26840802. Abstract
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load. Pareto D, Sastre-Garriga J, Aymerich FX, Auger C, Tintoré M, Montalban X, Rovira A Neuroradiology. 2016 Feb 4. Epub 2016 Feb 04. PMID: 26847633. Abstract
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy. Adachi H, Ishihara K, Tachibana H, Oka N, Higuchi Y, Takashima H, Yoneda Y, Kageyama Y Muscle Nerve. 2016 Feb 3. PMID: 26840509. Abstract
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Opsahl JA, Vaudel M, Guldbrandsen A, Aasebø E, van Pesch V, Franciotta D, Myhr K-M, Barsnes H, Berle M, Torkildsen Ø, et al. Proteomics. 2016 Feb 3. PMID: 26841090. Abstract
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study. Faivre A, Robinet E, Guye M, Rousseau C, Maarouf A, Le Troter A, Zaaraoui W, Rico A, Crespy L, Soulier E, et al. Mult Scler. 2016 Feb 2. PMID: 26838014. Abstract
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study. Preziosa P, Rocca MA, Pagani E, Stromillo M L, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, et al. Hum Brain Mapp. 2016 Feb 2. PMID: 26833969. Abstract
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis. Plavina T, Fox EJ, Lucas N, Muralidharan K K, Mikol D J Clin Pharmacol. 2016 Feb 2. PMID: 26835603. Abstract
Clinicopathological features in anterior visual pathway in neuromyelitis optica. Hokari M, Yokoseki A, Arakawa M, Saji E, Yanagawa K, Yanagimura F, Toyoshima Y, Okamoto K, Ueki S, Hatase T, et al. Ann Neurol. 2016 Feb 2. PMID: 26836302. Abstract
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Tan C T, Mao Z, Qiu W, Hu X, Wingerchuk DM, Weinshenker BG Neurology. 2016 Feb 2; 86(5):491-2. PMID: 26833940. Abstract
Reliability and Validity of Ratings of Perceived Exertion in Persons with Multiple Sclerosis. Cleland BT, Ingraham BA, Pitluck MC, Woo D, Ng AV Arch Phys Med Rehabil. 2016 Jan 30. PMID: 26836954. Abstract
SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent. Muñoz-Culla M, Irizar H, Sáenz-Cuesta M, Castillo-Triviño T, Osorio-Querejeta I, Sepúlveda L, de Munain A L, Olascoaga J, Otaegui D Sci Rep. 2016; 6:20126. PMID: 26831009. Abstract
Modeling the course and outcomes of MS is statistical twaddle-No. Bergamaschi R, Montomoli C Mult Scler. 2016 Feb; 22(2):142-4. PMID: 26830394. Abstract
Clustering of autoimmune diseases in patients with rosacea. Egeberg A, Hansen P R, Gislason G H, Thyssen J P J Am Acad Dermatol. 2016 Jan 30. PMID: 26830864. Abstract
Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes. Taylor BV Mult Scler. 2016 Feb; 22(2):140-2. PMID: 26830393. Abstract
Multiple sclerosis - New treatment modalities. Totaro R, Di Carmine C, Marini C, Carolei A Indian J Med Res. 2015 Dec; 142(6):647-54. PMID: 26831413. Abstract
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy. Shan N-N, Dong L-L, Zhang X-M, Liu X, Li Y Crit Rev Oncol Hematol. 2016 Jan 19. PMID: 26830007. Abstract
Transient global amnesia revealing multiple sclerosis. Ozkul-Wermester O, Lefaucheur R, Macaigne V, Guegan-Massardier E, Bourre B Presse Med. 2016 Jan 29. PMID: 26830923. Abstract
Correction: The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model. Lee Y E, An J, Lee K-H, Kim S S, Song H J, Pyeon H, Nam H, Kang K, Joo K M PLoS One. 2016; 11(2):e0148720. Epub 2016 Feb 03. PMID: 26840900. Abstract
High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients. Hecker M, Fitzner B, Wendt M, Lorenz P, Flechtner K, Steinbeck F, Schröder I, Thiesen H-J, Zettl U K Mol Cell Proteomics. 2016 Feb 1. PMID: 26831522. Abstract
Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score. Schiavolin S, Giovannetti A M, Leonardi M, Brenna G, Brambilla L, Confalonieri P, Frangiamore R, Mantegazza R, Moscatelli M, Clerici V T, et al. Neurol Sci. 2016 Feb 3. Epub 2016 Feb 03. PMID: 26842465. Abstract
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. Leszek J, Barreto GE, Gąsiorowski K, Koutsouraki E, Ávila-Rodrigues M, Aliev G CNS Neurol Disord Drug Targets. 2016 Feb 2. PMID: 26831258. Abstract
Psoriasis and comorbidities. Epidemiological studies. Egeberg A Dan Med J. 2016 Feb; 63(2). PMID: 26836804. Abstract
Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome. Canaday S, Rompala J, Rowles J, Fisher J, Holt D J Extra Corpor Technol. 2015 Dec; 47(4):228-30. PMID: 26834285. Abstract
Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells. Li Y, Du X-L, He B-P Neurochem Res. 2016 Feb 3. Epub 2016 Feb 03. PMID: 26842931. Abstract
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder. Kim W, Lee J E, Kim S, Huh S Y, Hyun J W, Jeong I H, Park M S, Cho J Y, Lee S H, Lee K S, et al. J Clin Neurol. 2016 Jan 28. PMID: 26833983. Abstract
Primary progressive multiple sclerosis-why we are failing. Segal BM, Stüve O Lancet. 2016 Jan 27. Epub 1969 Dec 31. PMID: 26827076. Abstract
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy]. Nogués MA, Varela FJ, Seminario G, Insúa MC, Bezrodnik L Medicina (B Aires). 2016; 76(1):36-9. PMID: 26826992. Abstract
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis. Swaroop S, Sengupta N, Suryawanshi A R, Adlakha YK, Basu A J Neuroinflammation. 2016; 13(1):27. Epub 2016 Feb 02. PMID: 26838598. Abstract
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin? Masi G, Annunziata P Autoimmun Rev. 2016 Jan 28. PMID: 26827908. Abstract
Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors. Tang X, Wang S, Bai Y, Wu J, Fu L, Li M, Xu Q, Xu Z-Q D, Alex Zhang Y, Chen Z Stem Cell Res. 2016 Jan 15; 16(2):236-242. PMID: 26826927. Abstract
[Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis]. Di Marco J, De Broglie C, Manceau P, Weglinski L, Lebreton F, Verrollet D, Amarenco G Prog Urol. 2016 Jan 27. PMID: 26826771. Abstract
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis. Ensari I, Sandroff BM, Motl RW Anxiety Stress Coping. 2016 Feb 1:1-29. PMID: 26828264. Abstract
Depression during multiple sclerosis relapse: relation to disability and relapse severity. Šabanagić-Hajrić S, Suljić E, Sulejmanpašić-Arslanagić G Med Glas (Zenica). 2016 Feb 1; 13(1):44-9. PMID: 26827706. Abstract
White Matter MS-Lesion Segmentation Using a Geometric Brain Model. Strumia M, Schmidt F, Anastasopoulos C, Granziera C, Krueger G, Brox T IEEE Trans Med Imaging. 2016 Jan 26. PMID: 26829786. Abstract
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients. Teniente-Serra A, Grau-López L, Mansilla JM, Fernández-Sanmartín M, Ester Condins A, Ramo-Tello C, Martínez-Cáceres E Autoimmunity. 2016 Feb 1:1-10. PMID: 26829210. Abstract
Cardiac Sympathetic Hyperactivity in a Patient with Guillain-Barré Syndrome: An Analysis Using Cardiac [(123)I] Metaiodobenzylguanidine (MIBG) Scintigraphy. Tanaka Y, Satomi K Intern Med. 2016; 55(3):299-302. Epub 2016 Feb 01. PMID: 26831028. Abstract
A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility. O'Meara RW, Cummings SE, Michalski J-P, Kothary R BMC Neurosci. 2016; 17(1):7. Epub 2016 Feb 01. PMID: 26831726. Abstract
A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy. Hong Y B, Joo J, Hyun Y S, Kwak G, Choi Y-R, Yeo H K, Jwa D H, Kim E J, Mo W M, Nam S H, et al. PLoS Genet. 2016 Feb; 12(2):e1005829. Epub 2016 Feb 01. PMID: 26828946. Abstract
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages. D'Souza CA, Zhao F L, Li X, Xu Y, Dunn SE, Zhang L PLoS One. 2016; 11(2):e0148439. Epub 2016 Feb 01. PMID: 26828924. Abstract
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. Lin C-C, Bradstreet TR, Schwarzkopf EA, Jarjour NN, Chou C, Archambault AS, Sim J, Zinselmeyer BH, Carrero JA, Wu GF, et al. J Exp Med. 2016 Feb 8; 213(2):251-71. Epub 2016 Feb 01. PMID: 26834156. Abstract
RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis. Lee J-K, Kannarkat GT, Chung J, Joon Lee H, Graham KL, Tansey MG J Neuroinflammation. 2016; 13(1):24. Epub 2016 Feb 01. PMID: 26831924. Abstract
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Wang D, Li S-P, Fu J-S, Bai L, Guo L Int J Dev Neurosci. 2016 Apr; 49:60-6. Epub 2016 Jan 28. PMID: 26827767. Abstract
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination. Lin Y C, Winokur P, Blake A, Wu T, Manischewitz J, King LR, Romm E, Golding H, Bielekova B Neurol Neuroimmunol Neuroinflamm. 2016 Feb; 3(1):e196. Epub 2016 Jan 27. PMID: 26848487. Abstract
Neurorehabilitation for Multiple Sclerosis Patients with Emotional Dysfunctions. Hung Y, Yarmak P Front Neurol. 2015; 6:272. Epub 2016 Jan 25. PMID: 26834694. Abstract
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis. Zhou FQ, Gong HH, Chen Q, Wang B, Peng Y, Zhuang Y, Zee C-S Front Hum Neurosci. 2016; 10:2. Epub 2016 Jan 25. PMID: 26834600. Abstract
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt. El-Tallawy HN, Farghaly W M, Badry R, Metwally NA, Shehata GA, Rageh TA, Hamed M A E, Kandil MR Neuropsychiatr Dis Treat. 2016; 12:155-8. Epub 2016 Jan 13. PMID: 26834477. Abstract
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis. Moon Y, Wajda DA, Motl RW, Sosnoff JJ Mult Scler Int. 2015; 2015:964790. Epub 2015 Dec 30. PMID: 26843986. Abstract
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Storoni M, Plant GT Mult Scler Int. 2015; 2015:681289. Epub 2015 Dec 29. PMID: 26839705. Abstract
Medicinal cannabis. Murnion B Aust Prescr. 2015 Dec; 38(6):212-5. Epub 2015 Dec 01. PMID: 26843715. Abstract
Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis. Kolahkaj B, Zargar F Nurs Midwifery Stud. 2015 Dec; 4(4):e29655. Epub 2015 Dec 01. PMID: 26835467. Abstract
Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder. Roman-Filip C, Ungureanu A, Cernuşcă-Miţaru M Neurol Neurochir Pol. 2016; 50(1):55-8. Epub 2015 Nov 24. PMID: 26851692. Abstract
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis. Sharma P, Morrow SA, Owen RJ Prim Care Companion CNS Disord. 2015; 17(5). Epub 2015 Oct 29. PMID: 26835163. Abstract
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder. Hyun J-W, Kim S-H, Jeong I H, Joung A, Kim J-H, Cho H J, Kim J H, Kim H J Sleep Med. 2016 Jan; 17:121-3. Epub 2015 Oct 22. PMID: 26847984. Abstract
Bevacizumab is safe in acute relapses of neuromyelitis optica. Mealy MA, Shin K, John G, Levy M Clin Exp Neuroimmunol. 2015 Nov 1; 6(4):413-418. Epub 2015 Aug 24. PMID: 26834844. Abstract
Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosis. Ezeugwu V, Klaren RE, Hubbard EA, Manns P T, Motl RW Prev Med Rep. 2015; 2:241-6. Epub 2015 Apr 01. PMID: 26844077. Abstract
Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy. Motuzova Y, di Sapio A, Capobianco M, Sala A, Marnetto F, Malucchi S, Bertolotto A Neurol Ther. 2015 Jun; 4(1):53-60. Epub 2015 Mar 06. PMID: 26847675. Abstract
A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms. Souri E, Zargarpoor M, Mottaghi S, Ahmadkhaniha R, Kebriaeezadeh A Sci Pharm. 2015; 83(1):85-93. Epub 2014 Sep 23. PMID: 26839803. Abstract